Papers

6 March 2024

An antigen-specific immunotherapeutic, AKS-107, deletes insulin-specific B cells and prevents murine autoimmune diabetes

26 February 2024

Immunogenicity phase II study evaluating booster capacity of nonadjuvanted AKS-452 SARS-Cov-2 RBD Fc vaccine

27 May 2022

Ultra-long-acting recombinant insulin for the treatment of diabetes mellitus in dogs

16 June 2021

An ultra-long-acting recombinant insulin for the treatment of diabetes mellitus in cats

16 January 2021

Disrupting Insulin and IGF Receptor Function in Cancer

15 February 2020

Abstract P1-21-05: A novel long-acting insulin for cancer therapy reduces xenograft tumor growth

23 February 2023

A randomized phase I/II safety and immunogenicity study of the Montanide-adjuvanted SARS-CoV-2 spike protein-RBD-Fc vaccine, AKS-452

23 February 2022

Phase I interim results of a phase I/II study of the IgG-Fc fusion COVID-19 subunit vaccine, AKS-452

15 February 2022

Abstract P4-02-01: Targeting insulin receptor in estrogen receptor positive breast cancer

16 October 2021

Development of an IgG-Fc fusion COVID-19 subunit vaccine, AKS-452